Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - gemcitabine - powder for solution for infusion - gemcitabine 1 g - antineoplastic agents

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg/ml - antineoplastic agents

Kenya - English - Pharmacy and Poisons Board

gemcitabine hydrochloride - concentrate for solution for infusion - 1 ml contains 11.4 mg gemcitabine hydrochloride… - gemcitabine

Kenya - English - Pharmacy and Poisons Board

gemcitabine hydrochloride - concentrate for solution for infusion - 1 ml contains 11.4 mg gemcitabine hydrochloride… - gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine - concentrate for solution for infusion - 100 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - gemcitabine hydrochloride (unii: u347pv74il) (gemcitabine - unii:b76n6sbz8r) - gemcitabine in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. gemcitabine in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. gemcitabine in combination with cisplatin is indicated for the first-line treatment of patients with inoperable, locally advanced (stage iiia or iiib), or metastatic (stage iv) non-small cell lung cancer (nsclc). gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable stage ii or stage iii) or metastatic (stage iv) adenocarcinoma of the pancreas. gemcitabine is indicated for patients previously treated with fluorouracil. gemcitabine for injection usp is contraindicated in patients with a known hypersensitivity to gemcitabine.

United States - English - NLM (National Library of Medicine)

hameln rds gmbh - gemcitabine hydrochloride (unii: u347pv74il) (gemcitabine - unii:b76n6sbz8r) - gemcitabine 200 mg in 5 ml

United States - English - NLM (National Library of Medicine)

watson laboratories, inc. - gemcitabine hydrochloride (unii: u347pv74il) (gemcitabine - unii:b76n6sbz8r) - gemcitabine 200 mg in 5 ml